VivoSeq
Other

Laparoscopic Cholecystectomy

3

Pipeline Programs

29

Active Trials

3

Companies Involved

Laparoscopic Cholecystectomy is an early-stage landscape with 3 programs across 3 companies. The most active players are Fresenius Kabi Oncology Ltd., Milestone Pharmaceuticals Inc., Merck & Co..

Pipeline Metrics

Competitive Density

44/100

Pipeline Velocity

48/100

Mech. Concentration

100/100

Completion Rate

94/100

Attrition Rate

3/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Trial Status

147

clinical trials

Completed83 · 56%
Unknown status30 · 20%
Not yet recruiting14 · 10%
Recruiting13 · 9%
Withdrawn3 · 2%
Terminated2 · 1%
Other2 · 1%

Trial Activity

147 trials

Page 1 of 10

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)